Papers, latest, tagged clear

  1. Newhouse, J. P. (1989). Do unprofitable patients face access problems? Health Care Financing Review.

  2. Dafny, L. S. (2005). How Do Hospitals Respond to Price Changes? American Economic Review.

  3. Sallee, J. M., & Slemrod, J. (2012). Car Notches: Strategic Automaker Responses to Fuel Economy Policy. Journal of Public Economics.

  4. Budish, E., Roin, B. N., & Williams, H. (2015). Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials. American Economic Review.

  5. Gupta, A., La Forgia, A., & Sacarny, A. (2026). Turbocharging Profits? Contract Gaming and Revenue Allocation in Healthcare. American Economic Journal: Applied Economics.

  6. Kao, J. (2025). Information Disclosure and Competitive Dynamics: Evidence from the Pharmaceutical Industry. Management Science.

  7. Banerjee, S., & Lin, P. (2003). Downstream R&D, raising rivals’ costs, and input price contracts. International Journal of Industrial Organization.

  8. Gray, C., Alpert, A., & Sood, N. (2026). Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market. American Economic Journal: Applied Economics.

  9. Krieger, J. L. (2021). Trials and Terminations: Learning from Competitors’ R&D Failures. Management Science.